59
Participants
Start Date
July 30, 2018
Primary Completion Date
April 3, 2025
Study Completion Date
July 17, 2025
Vedolizumab
Vedolizumab intravenous infusion
BAZ Megyei Korhaz es Egyetemi Oktatokorhaz, Miskolc
Debreceni Egyetem Klinikai Kozpont, Debrecen
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged
Columbia University Medical Center, New York
Children's Center for Digestive Healthcare, Atlanta
Nemours Childrens Specialty Care - Jacksonville, Jacksonville
The Edmond and Lily Safra Children's Hospital - Sheba Medical Center, Ramat Gan
Kharkiv Regional Clinical Children's Hospital, Kharkiv
Hopital Necker-Enfants Malades, Paris
Texas Children's Hospital, Houston
Cedars-Sinai Medical Center, Los Angeles
Children's Hospital of Orange County, Orange
University of California San Francisco, San Francisco
Seattle Children's Hospital, Seattle
Carmel Medical Center, Haifa
Schneider Children's Medical Center of Israel, Petach Tiqwa
Tel Aviv Sourasky Medical Center, Tel Aviv
Shaare Zedek Medical Center, Jerusalem
Connecticut Children's Medical Center, Hartford
Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow
Gabinet Lekarski Dr. Hab. N. Med. Bartosz Korczowski, Rzeszów
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi Osrodek Pediatryczny im Marii Konopnic, Lodz
Barts and The London NHS Trust, London
Lead Sponsor
Takeda Development Center Americas, Inc.
INDUSTRY
Takeda
INDUSTRY